| Schedule of Segment Reporting Information, by Segment |
The following table shows the segment revenue, significant segment expenses and net loss (dollars in thousands): | | | | | | | | | | | | | Three Months Ended
March 31, | | 2026 | | 2025 | | (unaudited) | Total revenues | $ | 207,705 | | | $ | 149,824 | | | Less: Significant segment expenses: | | | | | Cost of revenues | 23,391 | | | 15,763 | | Selling expenses | 66,278 | | | 42,614 | | Marketing expenses | 20,697 | | | 20,664 | | | General and administrative expenses | 38,198 | | | 26,666 | | Research and development expenses
| | | | External development program expenses: | | | | ONAPGO | 261 | | | 472 | | | SPN-820 | 1,849 | | | 4,763 | | SPN-817(b) | 16,557 | | | 3,571 | | | Qelbree | 2,364 | | | 4,413 | | ZURZUVAE | 82 | | | — | | Early-stage programs and other expenses | 6,565 | | | 3,213 | | Total external development program expenses | 27,678 | | | 16,432 | | Internal employee-related expenses | 11,760 | | | 10,495 | | Total research and development expenses | 39,438 | | | 26,927 | | Other segment items(a) | 21,996 | | | 29,017 | | | Net loss | $ | (2,293) | | | $ | (11,827) | |
(a) Other segment items include amortization of intangible assets, contingent consideration loss, net interest and other income, and income tax expense (benefit) whose amounts are disclosed in the condensed consolidated statement of loss. (b) Includes amount related to Biscayne amendment. Refer to Note 17, Commitments and Contingencies.
|